Literature DB >> 29634693

Catalyzing the field of precision oncology, one basket at a time.

William Pao1, Imola Fodor2.   

Abstract

Mesh：

Year:  2018        PMID： 29634693     DOI： 10.1038/nm.4530

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  5 in total

1.  Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both.

Authors:  Janet Woodcock; Lisa M LaVange
Journal:  N Engl J Med       Date:  2017-07-06       Impact factor: 91.245

2.  Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study.

Authors:  John D Hainsworth; Funda Meric-Bernstam; Charles Swanton; Herbert Hurwitz; David R Spigel; Christopher Sweeney; Howard Burris; Ron Bose; Bongin Yoo; Alisha Stein; Mary Beattie; Razelle Kurzrock
Journal:  J Clin Oncol       Date:  2018-01-10       Impact factor: 44.544

3.  Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.

Authors:  David M Hyman; Igor Puzanov; Vivek Subbiah; Jason E Faris; Ian Chau; Jean-Yves Blay; Jürgen Wolf; Noopur S Raje; Eli L Diamond; Antoine Hollebecque; Radj Gervais; Maria Elena Elez-Fernandez; Antoine Italiano; Ralf-Dieter Hofheinz; Manuel Hidalgo; Emily Chan; Martin Schuler; Susan Frances Lasserre; Martina Makrutzki; Florin Sirzen; Maria Luisa Veronese; Josep Tabernero; José Baselga
Journal:  N Engl J Med       Date:  2015-08-20       Impact factor: 91.245

4.  AACR Project GENIE: Powering Precision Medicine through an International Consortium.

Authors: 
Journal:  Cancer Discov       Date:  2017-06-01       Impact factor: 39.397

5.  HER kinase inhibition in patients with HER2- and HER3-mutant cancers.

Authors:  David M Hyman; Sarina A Piha-Paul; Helen Won; Jordi Rodon; Cristina Saura; Geoffrey I Shapiro; Dejan Juric; David I Quinn; Victor Moreno; Bernard Doger; Ingrid A Mayer; Valentina Boni; Emiliano Calvo; Sherene Loi; Albert C Lockhart; Joseph P Erinjeri; Maurizio Scaltriti; Gary A Ulaner; Juber Patel; Jiabin Tang; Hannah Beer; S Duygu Selcuklu; Aphrothiti J Hanrahan; Nancy Bouvier; Myra Melcer; Rajmohan Murali; Alison M Schram; Lillian M Smyth; Komal Jhaveri; Bob T Li; Alexander Drilon; James J Harding; Gopa Iyer; Barry S Taylor; Michael F Berger; Richard E Cutler; Feng Xu; Anna Butturini; Lisa D Eli; Grace Mann; Cynthia Farrell; Alshad S Lalani; Richard P Bryce; Carlos L Arteaga; Funda Meric-Bernstam; José Baselga; David B Solit
Journal:  Nature       Date:  2018-01-31       Impact factor: 49.962
  5 in total
  2 in total

1.  Personalized oncology and BRAFK601N melanoma: model development, drug discovery, and clinical correlation.

Authors:  Brian A Keller; Brian J Laight; Oliver Varette; Aron Broom; Marie-Ève Wedge; Benjamin McSweeney; Catia Cemeus; Julia Petryk; Bryan Lo; Bruce Burns; Carolyn Nessim; Michael Ong; Roberto A Chica; Harold L Atkins; Jean-Simon Diallo; Carolina S Ilkow; John C Bell
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-08       Impact factor: 4.553

Review 2.  Role of Targeted Therapy in Dilated Cardiomyopathy: The Challenging Road Toward a Personalized Approach.

Authors:  Job A J Verdonschot; Mark R Hazebroek; James S Ware; Sanjay K Prasad; Stephane R B Heymans
Journal:  J Am Heart Assoc       Date:  2019-06-01       Impact factor: 5.501
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.